Name | Norco Inc |
---|---|
Organization Name | Norco, Inc. |
Location | 223 W 3rd St, Moscow, Idaho 83843 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (208) 882-3571 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme - preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.
Families in the United States are making gains in education and health, two key factors in their overall well-being, a report released on Monday showed, adding to data that suggests the U.S. economy is slowly rebounding from the 2007-2009 recession. Still, the latest findings on the state of U.S. children and their parents by the Annie E. Casey Foundation found many families continue to struggle ... Most states also saw more children with health insurance, improvements in birth weights, and fewer youth deaths between 2005 and 2011, it said (Heavey, 6/24).
Favorable results have led to crizotinib gaining approval for the treatment of advanced stage ALK-positive non-small cell lung cancer (NSCLC) in Japan, the United States, Canada, and several other countries in Europe and Asia.
The Mount Sinai Medical Center has taken the lead in developing the largest treatment and monitoring program for emergency responders, recovery workers, residents, and area workers who were affected by the terrorist attacks in New York City on September 11, 2001.
GenVec, Inc. announced today that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue.
› Verified 3 days ago
NPI Number | 1225192859 |
Organization Name | NORCO, INC |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 223 W 3rd St, Moscow, ID 83843 |
Phone Number | 208-882-3571 |
News Archive
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme - preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.
Families in the United States are making gains in education and health, two key factors in their overall well-being, a report released on Monday showed, adding to data that suggests the U.S. economy is slowly rebounding from the 2007-2009 recession. Still, the latest findings on the state of U.S. children and their parents by the Annie E. Casey Foundation found many families continue to struggle ... Most states also saw more children with health insurance, improvements in birth weights, and fewer youth deaths between 2005 and 2011, it said (Heavey, 6/24).
Favorable results have led to crizotinib gaining approval for the treatment of advanced stage ALK-positive non-small cell lung cancer (NSCLC) in Japan, the United States, Canada, and several other countries in Europe and Asia.
The Mount Sinai Medical Center has taken the lead in developing the largest treatment and monitoring program for emergency responders, recovery workers, residents, and area workers who were affected by the terrorist attacks in New York City on September 11, 2001.
GenVec, Inc. announced today that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue.
› Verified 3 days ago
NPI Number | 1538940028 |
Organization Name | NORCO INC |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 5951 Airport Rd Bldg 1, Pullman, WA 99163 |
Phone Number | 208-882-3571 |
News Archive
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme - preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.
Families in the United States are making gains in education and health, two key factors in their overall well-being, a report released on Monday showed, adding to data that suggests the U.S. economy is slowly rebounding from the 2007-2009 recession. Still, the latest findings on the state of U.S. children and their parents by the Annie E. Casey Foundation found many families continue to struggle ... Most states also saw more children with health insurance, improvements in birth weights, and fewer youth deaths between 2005 and 2011, it said (Heavey, 6/24).
Favorable results have led to crizotinib gaining approval for the treatment of advanced stage ALK-positive non-small cell lung cancer (NSCLC) in Japan, the United States, Canada, and several other countries in Europe and Asia.
The Mount Sinai Medical Center has taken the lead in developing the largest treatment and monitoring program for emergency responders, recovery workers, residents, and area workers who were affected by the terrorist attacks in New York City on September 11, 2001.
GenVec, Inc. announced today that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue.
› Verified 3 days ago
News Archive
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme - preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.
Families in the United States are making gains in education and health, two key factors in their overall well-being, a report released on Monday showed, adding to data that suggests the U.S. economy is slowly rebounding from the 2007-2009 recession. Still, the latest findings on the state of U.S. children and their parents by the Annie E. Casey Foundation found many families continue to struggle ... Most states also saw more children with health insurance, improvements in birth weights, and fewer youth deaths between 2005 and 2011, it said (Heavey, 6/24).
Favorable results have led to crizotinib gaining approval for the treatment of advanced stage ALK-positive non-small cell lung cancer (NSCLC) in Japan, the United States, Canada, and several other countries in Europe and Asia.
The Mount Sinai Medical Center has taken the lead in developing the largest treatment and monitoring program for emergency responders, recovery workers, residents, and area workers who were affected by the terrorist attacks in New York City on September 11, 2001.
GenVec, Inc. announced today that it is discontinuing its Phase 3 clinical trial of TNFerade™ in patients with locally advanced pancreatic cancer based on results of an interim analysis. This interim analysis of overall survival, conducted after the 184th death (two-thirds of total expected events), was designed to determine whether the study should continue.
› Verified 3 days ago
Rite Aid Pharmacy 05421 Type: Medicare Supplier Location: 1810 W Pullman Rd, Moscow, Idaho 83843 Phone: (208) 882-3583 | |
Safeway Pharmacy #0383 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1320 S Blaine St, Moscow, Idaho 83843 Phone: (208) 882-2663 | |
Walmart Pharmacy 10-5869 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2470 W Pullman Rd, Moscow, Idaho 83843 Phone: (208) 882-1344 | |
Walgreens #12503 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 414 N Main St, Moscow, Idaho 83843 Phone: (208) 882-6076 |